FDA might not have all the answers to House Energy & Commerce Committee questions about the agency's interception of unapproved opioid drugs in international mail, but it has figures showing what it's up against.
The committee's Republican and Democrat leadership on June 8 submitted a letter asking FDA Commissioner Scott Gottlieb about work...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?